Latest stories on BLFS
BIOLIFE SOLUTIONS INC (BLFS) files 8-K
SEC 8-K50 · neutralgeneral
BioLife Solutions Sets October Vote on Cash‑and‑Stock Merger With Repligen
TipRanks55 · neutralm&a
Diamond Hill Bets on BioLife Solutions’ (BLFS) High Switching Cost
Yahoo Finance67 · bullishanalyst
Biolife Solutions Downgraded To Hold From Buy At Benchmark
The Fly48 · neutralanalyst
BIOLIFE SOLUTIONS INC (BLFS) files 8-K
SEC 8-K50 · neutralgeneral
BioLife Solutions Reports Second Quarter 2026 Financial Results
PR Newswire63 · neutralearnings
BioLife Details Strategic Repligen Merger Communication to Staff
TipRanks56 · neutralm&a
BIOLIFE SOLUTIONS INC (BLFS) files 8-K
SEC 8-K50 · neutralgeneral
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD
PR Newswire50 · neutralgeneral
BLFS Faces Shareholder Scrutiny as Sale Terms Questioned: Are Ordinary Holders Getting a Fair Deal?
July 28, 2026
MarketChameleon38 · neutralgeneral
Canaccord reiterates Hold on Repligen stock after BioLife deal
Investing.com Analyst Ratings50 · neutralanalyst
Repligen Corporation (RGEN) BioLife Solutions, Inc., - M&A Call - Slideshow
Seeking Alpha50 · neutralm&a
TD Cowen downgrades BioLife Solutions stock rating on Repligen deal
Investing.com Analyst Ratings34 · bearishanalyst
BIOLIFE SOLUTIONS INC (BLFS) files 8-K
SEC 8-K50 · neutralgeneral
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Yahoo Top63 · neutralm&a
BLFS Merger Faces Scrutiny as Halper Sadeh LLC Investigates Deal Price for Shareholders
MarketChameleon42 · neutralgeneral
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
Investing.com Markets63 · neutralm&a
Repligen to Acquire BioLife, Expanding Cell Therapy Reach
TipRanks67 · bullishm&a
Repligen’s $1.5B BioLife Acquisition Poised to Reshape Cell Therapy Market with Accretive Growth
July 22, 2026
MarketChameleon67 · bullishm&a
Repligen's $1.5 Billion BioLife Acquisition Boosts Cell Therapy Market Presence and Earnings Outlook
MarketChameleon73 · bullishm&a
Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business
Yahoo Finance65 · bullishm&a
Repligen to buy BioLife Solutions in $1.5 billion deal
Reuters63 · neutralm&a
Repligen to buy BioLife Solutions in $1.5B stock-and-cash deal
Seeking Alpha67 · bullishm&a
BioLife is said to have drawn takeover interest from Repligen
Seeking Alpha63 · neutralm&a